Skip to main content

Genetic Disease

A common drug may help treat a rare genetic disease



A drug found in almost every medicine cabinet may be a treatment for a rare genetic disease.

Ibuprofen may help children with mutations in a gene called MAN1B1, a study in fruit flies suggests. Geneticist Clement Chow of the University of Utah in Salt Lake City reported the results November 6 at the American Society of Human Genetics annual meeting.

The MAN1B1 protein normally strips a sugar called mannose off misfolded proteins, targeting them for disposal. Kids who inherit two faulty copies of the MAN1B1 gene have developmental delays, are prone to obesity and aggression, have distinctive facial features and a host of other issues. No cure or treatment for the disease, called MAN1B1-congenital disorder of glycosylation, currently exists.

Chow and colleagues decided to test a battery of already approved drugs to see if any might help. This type of drug repurposing research has become common. The approach is “important because people living with rare diseases can’t just sit around waiting for a drug to be developed, which may take decades,” Chow said.

The team made fruit flies in which MAN1B1 was mutated in the flies’ eyes. The mutation causes the eyes to be small and rough. The researchers tested about 1,500 existing drugs on the flies. Of those, 51 restored the flies’ eyes to the usual large, ruby red state and 47 made the condition worse. Of the drugs that returned the eyes to normal, nine were nonsteroidal anti-inflammatory drugs, or NSAIDs, including ibuprofen and related pain relievers.

Those drugs inhibit the action of enzymes known as COX1 and COX2 to reduce inflammation in the body. In flies without MAN1B1, COX activity was high. Treating with ibuprofen could lower it. And genetically lowering the amount of COX also restored the normal eye shape, indicating that the overzealous enzyme is a problem when MAN1B1 isn’t around to run a quality check on it.

Flies that completely lack MAN1B1 in their bodies also had prolonged seizures when researchers banged the vial containing the flies on the counter. But treating the flies with ibuprofen made the flies less seizure-prone.

Results from the fly experiments were promising enough that a doctor started three children who have MAN1B1 mutations on low-dose ibuprofen. The results are preliminary, but “things are looking fairly positive,” Chow said.

Genetic mutations, gene expression, molecular pathways, transcription factors, epigenetics, protein synthesis, signal transduction, gene regulation, genetic variants, gene-environment interaction, RNA splicing, chromosomal rearrangements, protein-coding genes, epistasis, gene editing, functional genomics, gene silencing, phenotypic traits, heritability, genetic disorders.

#Genetics #GeneExpression #MutationEffects #MolecularPathways #TranscriptionFactors #Epigenetics #ProteinSynthesis #GeneRegulation #GeneVariants #GeneEnvironment #RNA #ChromosomalChanges #ProteinCoding #Epistasis #GeneEditing #FunctionalGenomics #GeneSilencing #Traits #Heritability #GeneticDisorders

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more